MiNK Therapeutics, Inc.INKTNASDAQ
Loading
Free Cash Flow Growth AcceleratingAccelerating
Percentile Rank80
Studio
Year-over-Year Change

Year-over-year free cash flow growth rate

Latest
39.66%
↑ 33796% vs avg
Percentile
P80
Within normal range
Streak
3 yr
Consecutive growthAccelerating
Average
0.12%
Historical baseline
PeriodValue
202439.66%
202317.16%
2022-46.20%
2021-55.06%
202045.14%
20190.00%